Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Structural and chemical-genetic analysis of diphosphoinositol signaling
FY 2009-10
Summary
Our cells require precisely coordinated signals for their normal functions and disruption of these signals can lead to various diseases, such as cancer. Inositol phosphates (IPs) are a class of small molecules that act as signals in every type of cell in our bodies and they perform critical roles in regulating a variety of cellular processes. Diphosphoinositol polyphosphates (diIPs) are newly discovered class of IPs that regulates intracellular communication and DNA repair. There are only 2 types of enzymes that produce these diIPs. They are called the inositol hexaphosphate kinase (IP6K) and the inositol pyrophosphate synthetase (IPS). Much is known about the IP6K. It's important for excretion of insulin from the pancreas, as animals with inactive IP6K possess low insulin levels in the blood and IP6K has also been shown to sensitize cancer cells to numerous anti-cancer drugs. The goal of my research project is to explore the structure and the functions of the other diIP-producing enzyme: IPS. Much less is known about IPS than IP6K. Does it also control insulin release from the pancreas? Can it also sensitize cancer cells to drugs? We do not yet have answers to these questions, but my overall aim is to generate the tools to help answer them. IPS is different than IP6K in that it has two parts, one part that generates the diIP signal and another that may destroy it. This unusual feature makes it a potentially important enzyme for the control of cellular diIP levels. My aim is to determine the atomic-resolution structure of the IPS. This high-resolution snapshot of the protein will reveal details about the protein not available from other techniques. To understand the role of diIPs in the cells, I plan to specifically inactivate the enzymes that form diIPs and look at the resulting changes in the cells. Understanding how these diIPs are produced and what role they play could lead to a new target system for development of both diabetes and cancer therapeutics.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
200330
Name
Machkalyan Gayane
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Structural and chemical-genetic analysis of diphosphoinositol signaling
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cellular Signaling; Inositol Phosphate Signaling; Protein Purification; Site-Directed Mutagenesis; Specific Protein Inhibitors; X-Ray Crystalography
Abstract
Our cells require precisely coordinated signals for their normal functions and disruption of these signals can lead to various diseases, such as cancer. Inositol phosphates (IPs) are a class of small molecules that act as signals in every type of cell in our bodies and they perform critical roles in regulating a variety of cellular processes. Diphosphoinositol polyphosphates (diIPs) are newly discovered class of IPs that regulates intracellular communication and DNA repair. There are only 2 types of enzymes that produce these diIPs. They are called the inositol hexaphosphate kinase (IP6K) and the inositol pyrophosphate synthetase (IPS). Much is known about the IP6K. It's important for excretion of insulin from the pancreas, as animals with inactive IP6K possess low insulin levels in the blood and IP6K has also been shown to sensitize cancer cells to numerous anti-cancer drugs. The goal of my research project is to explore the structure and the functions of the other diIP-producing enzyme: IPS. Much less is known about IPS than IP6K. Does it also control insulin release from the pancreas? Can it also sensitize cancer cells to drugs? We do not yet have answers to these questions, but my overall aim is to generate the tools to help answer them. IPS is different than IP6K in that it has two parts, one part that generates the diIP signal and another that may destroy it. This unusual feature makes it a potentially important enzyme for the control of cellular diIP levels. My aim is to determine the atomic-resolution structure of the IPS. This high-resolution snapshot of the protein will reveal details about the protein not available from other techniques. To understand the role of diIPs in the cells, I plan to specifically inactivate the enzymes that form diIPs and look at the resulting changes in the cells. Understanding how these diIPs are produced and what role they play could lead to a new target system for development of both diabetes and cancer therapeutics.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Machkalyan, Gayane
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~